MT Genex Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
MT Genex has a total shareholder equity of ¥3.9B and total debt of ¥112.0M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are ¥4.8B and ¥853.0M respectively. MT Genex's EBIT is ¥364.0M making its interest coverage ratio -36.4. It has cash and short-term investments of ¥1.7B.
Anahtar bilgiler
2.9%
Borç/özkaynak oranı
JP¥112.00m
Borç
Faiz karşılama oranı | -36.4x |
Nakit | JP¥1.74b |
Eşitlik | JP¥3.90b |
Toplam yükümlülükler | JP¥853.00m |
Toplam varlıklar | JP¥4.75b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
There's No Escaping MT Genex Corporation's (TSE:9820) Muted Earnings
Aug 06Why Investors Shouldn't Be Surprised By MT Genex Corporation's (TSE:9820) Low P/E
Mar 08MT Genex (TYO:9820) Has More To Do To Multiply In Value Going Forward
Apr 28You Have To Love MT Genex Corporation's (TYO:9820) Dividend
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In MT Genex Corporation's TYO:9820) Stock?
Feb 11Will MT Genex's (TYO:9820) Growth In ROCE Persist?
Dec 31Is MT Genex Corporation (TYO:9820) A Smart Pick For Income Investors?
Nov 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 9820's short term assets (¥4.2B) exceed its short term liabilities (¥511.0M).
Uzun Vadeli Yükümlülükler: 9820's short term assets (¥4.2B) exceed its long term liabilities (¥342.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 9820 has more cash than its total debt.
Borcun Azaltılması: 9820's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Borç Kapsamı: 9820's debt is well covered by operating cash flow (257.1%).
Faiz Kapsamı: 9820 earns more interest than it pays, so coverage of interest payments is not a concern.